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Abstract 
 
Background  
Laparoscopic cholecystectomy (LC) is recommended for patients with choledocholithiasis after 
ERCP with sphincterotomy (ES) and stone extraction.  
 
Aim  
We designed decision model to address whether ES alone versus ES followed by LC (ES + LC) 
is the optimal treatment in high-risk patients with choledocholithiasis.  
 
Methods  
Our cohort were patients with obstructive jaundice who have undergone an ES with biliary 
clearance. Recurrent biliary complications over 2-year period stratified by gallbladder status 
(in/out) and age-stratified surgical complication rates were obtained from the literature. Failure of 
therapy was defined as either recurrent symptoms or death attributed to biliary complications.  
 
Results  
For age 70–79 years, ES failed in 15% whereas ES LC failed in 17% of cases. Mortality in the EC 
LC group was 3.4 times that of the ES alone cohort. For age 80+ years, ES was dominant with an 
incremental success rate of 8%. Mortality in the ES LC was 7.6 times that of ES. For age <70, ES 
LC was the dominant strategy with an incremental success rate 5%. Sensitivity analysis in the 
groups confirmed our conclusions.  
 
Conclusions  
Management of choledocholithiasis by ES and stone clearance, but without cholecystectomy, 
should be considered for patients aged 70+. For low-risk patients, ES LC should be performed to 
prevent recurrent biliary complications.  
_____________________________________________________________________________ 
 
INTRODUCTION  
 
Endoscopic retrograde cholangiopancreatography (ERCP) with endoscopic 
sphincterotomy (ES) is accepted as the therapy of choice for patients with stones 
in the bile duct.1–3 Endoscopic stone extraction is successful in over 96% of 
patients3–5 with a low procedure-related morbidity (5.8%) and mortality 
(0.2%).Subsequent laparoscopic cholecystectomy (LC) is the standard treatment 
in those patients with concomitant gall-bladder stones. The rationale for 
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cholecystectomy is to prevent biliary complications such as acute cholecystitis, 
biliary colic, recurrent biliary stones, cholangitis and biliary pancreatitis. Many 
patients with biliary stones are elderly and have multiple comorbid conditions and 
are thus poor surgical candidates. Postoperative mortality and morbidity increase 
with age and associated comorbid diseases.6, 7 Several groups have proposed 
that endoscopic extraction of bile duct stones, with the gall-bladder left in situ, 
could be an option in high surgical risk patients presenting with jaundice 
secondary to choledocholithiasis.8 Although endoscopic therapy may carry lower 
immediate morbidity or mortality, late biliary complications are not uncommon. 
The decision whether to proceed to surgery is further complicated by the fact that 
the morbidity and mortality of LC have declined with greater surgical 
experience.9, 10 Additionally, some of the studies that advocate use of ES in high-
risk patients do not agree with the definition of high surgical risk.11, 2  
We designed decision analysis to address whether ES alone vs. ES followed by 
LC (ES + LC) is the optimal treatment modality in high-risk patients with 
choledocholithiasis.  
 
PATIENTS AND METHODS  
 
Literature review  
 
A Medline research looking at English language articles from 1990 to the present 
was performed for variation of the following terms: ERCP, ES, LC, elderly, 
gallstones, cholelithiasis, morbidity and mortality. Bibliographies of accepted 
articles were reviewed and we searched recent issues of peer-review journals of 
gastroenterology and surgery. Only studies that had more than 10 patients and 
outcome data that could be abstracted were used. Updated series took 
precedence over older studies from the same institution. Some variability was 
noted in the studies reporting testing characteristics and complications rates for 
the different variables. Weighted mean values for each parameter were 
calculated from the usable trials and applied to our decision tree. All probabilities 
for clinical inputs in the model, as well as the range tested in the sensitivity 
analysis, are summarized in Tables 1 and 2. 
 
Decision analytical model  
 
Using a decision analysis software program, DATA 3.5 (TreeAge Software Inc., 
Williamstown, MA, USA), we evaluated the clinical outcomes and recurrent biliary 
complications in patients with cholelithiasis within 2-year period in three different 
age groups: (i) patients younger than 70 years. (ii) patients of age 70–79 years 
(base cohort). (iii) patients of age 80 years or more. The decision tree used in the 
analysis is illustrated in Figure 1.  
 
For each of the age groups, the analysis started with cohort of 100 hypothetical 
patients with intact gallbladders presenting with obstructive jaundice because of 
_____________________________________________________________________________ 
© 2006 The Authors.  This is the authors’ version prior to publication in Alimentary Pharmacology 
& Therapeutics 24(7):1059-1066, October 2006.  The definitive version is available at 
www.blackwell-synergy.com (http://dx.doi.org/10.1111/j.1365-2036.2006.03103.x)  Journal 
compilation © 2006 Blackwell Publishing.   
cholelithiasis. All patients underwent successful ERCP with ES and biliary 
clearance without complications. Patients were then assigned to two groups: 
group I (ES + LC), in which patients were treated with LC to remove the gall-
bladder following ES and group II (ES only), in which the gall-bladder was left in 
situ after ES.  
 
Patients in group I underwent an ES followed by an LC. The decision model was 
divided into that subset of patients who had immediate complications following 
LC and those patients who had no surgical complications. In the group of 
patients who had immediate surgical complications, the mortality and morbidity of 
LC were modeled based on published rates in the literature. Those patients who 
did not die because of surgical complication nor had post-operative complications 
were then assessed for long-term recurrent biliary complications and mortality 
within 2-year period.  
 
Patients in group II underwent an ES and the gallbladder was left in situ. These 
patients were then assessed for long-term recurrent biliary complications and 
mortality within 2-year period.  
 
Appraisal of clinical outcomes  
 
The decision tree was used to evaluate the preferred treatment strategy for 
management of choledocholithiasis in patients in each of the three different age 
groups. Short-term operative mortality and morbidity were assessed. Failure of 
therapy was defined as either recurrent symptoms or death attributed to biliary 
complication.  
 
Sensitivity analysis  
 
The performance characteristics were varied to determine the threshold patient 
age and complication rates that would alter treatment strategies using one-way 
and multiple-way sensitivity analyses so as to detect its effect on the ultimate 
results.  
 
It is not realistic to rely upon one value for probabilities, as there is marked 
variability in outcomes seen in the literature. In doing sensitivity analysis, we can 
see whether changing the mortality and mortality rate alters the favored decision 
strategy. If it does not, this proves the robustness of the model. If it does alter the 
strategy, the model is considered to be sensitive to changes in the probability of 
that particular test. In the final analysis, this helps determine the most optimal 
treatment modality for patients with choledocholithiasis, who are at increased 
surgical risk.  
 
One-way sensitivity analyses were done by varying single variable baseline 
probabilities over credible range and then interpreting their effect on final 
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outcomes. For each scenario, one-way sensitivity analysis was performed, 
plotting success of therapy against surgical complications, to determine the 
optimal strategy to follow (ES + LC vs. ES alone). Three-way sensitivity analysis 
of recurrent complications in ES, ES LC and surgical morbidity was then 
performed to further validate the strength of the decision model.  
 
RESULTS  
 
Decision tree analysis  
 
Age less than 70 years  
 
In patients who were less than 70 years of age, the ES + LC was the dominant 
strategy. Patients with choledocholithiasis who underwent an ES followed by LC 
had a 90% overall success rate with 2-year mortality rate of 0.05 per 100 
patients. In comparison, patients with choledocholithiasis who underwent only an 
ES had an 85% overall success rate. The ES-only group had 2-year mortality 
rate of 0.1 per 100 patients, which was twice that of the ES + LC group. A one-
way sensitivity analysis identified threshold surgical complication rate of 9.8% 
(Figure 2), above which ES was the dominant strategy and further validated that 
in patients less than 70 years of age with biliary obstruction because of 
choledocholithiasis, ES followed by LC should be the treatment of choice. 
Patients who underwent only ES had lower overall success rate and higher 
mortality.  
 
Age 70–79 years (base cohort)  
 
In patients aged 70–79 (base cohort), ES alone was the dominant strategy when 
compared with ES + LC. The ES-alone group had an overall success rate of 85% 
when compared with the ES + LC group that had an 83% success rate. The ES-
alone group thus has an incremental success rate of 2%. The ES-alone group 
had 15% failure rate when compared with 17% in the ES + LC group. The 2-year 
mortality in the EC + LC group was 3.4 times that of the ES-alone cohort. One-
way sensitivity analysis determined threshold surgical complication rate of 10% 
(Figure 3), above which ES was the dominant strategy; therefore in patients of 
age 70–79 years with biliary obstruction because of choledocholithiasis, ES 
alone should be the treatment of choice. ES + LC have higher failure rates and 
mortality in this age group.  
 
Age 80 years and above  
 
For the cohort of age 80 years or more, ES was dominant with an overall 
success rate of 86% when compared with 78% in the ES + LC group. The ES-
only group, therefore, had an incremental success rate of 8% over ES + LC. 
Three-way sensitivity analysis of recurrent complications in ES, ES + LC and 
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surgical morbidity, identified ES as the dominant strategy in all cases except 
when biliary complications for ES  
exceeded 22.2% (range 6–24%). Mortality in the ES + LC group was 7.6 times 
that of the ES cohort. ES-alone group had an overall greater success rate and 
lower mortality rate compared with the ES + LC group.  
 
The decision analysis results are summarized in Table 3.  
 
DISCUSSION  
 
We constructed a decision analysis, attempting to simulate the clinical scenario 
of patient presenting with obstructive jaundice because of an obstructed common 
bile duct stone. Patients were stratified into three different age groups, and the 
model was used to determine the optimal management strategy. We found that 
ERCP with sphincterotomy (ES) and stone clearance, but without 
cholecystectomy, should be strongly considered for patients aged 70–79 (base 
cohort). In patients of age 80 years and above, ERCP with ES alone was the 
dominant strategy, largely because of increased surgical complication rates. For 
low-risk patients (less than 70 years of age), ES followed by LC should be 
performed to prevent recurrent biliary complications and decrease overall 
morbidity and mortality.  
 
Decision modeling uses complex clinical situation and is based on previously 
published data. It helps serve as an adjunct to clinical decision making. It should 
be remembered that decision modeling is subject to several limitations. The 
influences of factors such as patient preferences that may impact the choice of 
clinical approach are difficult to access. Our decision model has several 
limitations. The model has level of uncertainty when looking at the clinical 
assumptions. Like all decision models, the limitations may affect the validity and 
generalizability of our findings. Therefore, sensitivity analysis allows us to 
address this uncertainty by giving range of values to inputs prone to uncertainty. 
We have made number of simplifying assumptions so as to create working 
decision model that may not capture many of the subtleties that happen in clinical 
practice.  
 
Patients who present with obstructive jaundice secondary to bile duct stones 
usually undergo an ES followed by LC. Procedure complication rates from both 
elective and emergency ERCPs in the elderly are similar to those of the younger 
age groups, despite the geriatric population having more comorbidities.12, 13 A 
study by Clarke et al.14 showed that post-ERCP pancreatitis occurred in 5% of 
patients aged 85 or above. This was similar rate to younger patients.13 Although 
it is well documented that patients undergoing endoscopy can experience 
hypoxaemia, it is not clear whether this contributes to any associated 
complications.15, 16  
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As opposed to endoscopy, there is an increase in incidence of post-operative 
mortality and morbidity after cholecystectomy with advancing age. The elderly 
are at an increased risk for surgery because of concurrent comorbidities, 
decreased functional reserve and greater chance that surgery will be done on an 
emergency basis.10 Several studies have looked at the results of LC in the elderly 
population.17–20 The majority of these studies are compromised of small number 
of patients, and there are only two reports that focused out outcomes in 
octogenarians.21, 22 These studies have reported that when compared with 
younger patients, the elderly have more complications, higher rates of conversion 
to an open cholecystectomy, and longer post-operative hospitalization. Maxwell 
et al.22 compared 105 octogenarians to control group of 210 patients who were 
younger than 80 years. His study showed that patients older than 80 years 
required more emergency surgery (11% vs. 4.8%), had higher intra-operative 
complications (13% vs. 3.3%) and greater incidence of conversion to an open 
cholecystectomy (16% vs. 8.6%). The overall complication rate was also higher 
in octogenarians.  
 
Elective cholecystectomy after ES is still arguable. Certain surgical reports 
suggest that the presence of cholelithiasis is an indication for elective 
cholecystectomy after ES.23 Surgical sphincterotomy has been shown to prevent 
gallstone formation in prairie dogs.24, 25 In humans, ES stimulates gall-bladder 
motility and was thought to prevent further gallstone formation.26  
 
Boerma et al.27 did prospective, randomized trial in 120 patients with gall-bladder 
stones, who underwent an ES for common bile duct stones. Patients were then 
randomly allocated to wait-and-see for LC. The primary outcome was recurrence 
of biliary events during a 2-year follow-up. The mean age in this group of patients 
was 60 years. Of the patients allocated to wait-and-see, 47% had recurrent 
biliary complications over 2 years when compared with 2% in patients who 
underwent an LC. In this group of patients, ES alone was an inadequate therapy 
compared with ES + LC because of high recurrent biliary complications. Young 
patients tended to develop recurrent biliary complications the most. These 
findings were compatible with the conclusions in our study for low-risk patients 
(younger than 70 years), for which we recommended ES followed by LC to 
prevent recurrent biliary complications. It should be noted that the biliary 
complication rate in the wait-and-see group (47%) was significantly higher when 
compared with other similar trials. Several other trials 28–30 have also suggested 
ES LC as treatment of choice in younger low-risk patients with 
choledocholithiasis.  
 
Lai et al.31 looked at 140 patients (mean age 69 years) with intact gall-bladder, 
who underwent ES for clearance of stones in the bile duct. Of the 140 patients, 
46 underwent elective LC soon after sphincterotomy and 94 did not. There was 
no statistically significant difference in recurrent complications between patients 
without gall-bladders vs. the patients with intact gall-bladders. Therefore, elective 
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cholecystectomy after ES did not prevent the recurrent biliary complications in 
patients with cholelithiasis or nonfunctional or normal gall-bladder. Similar 
conclusions were drawn by Boytchev,32 in which late biliary complications after 
ES for choledocholithiasis in patients with gall-bladder in situ were rare (2% per 
year) in patients with mean age of 78 years.  
 
A recent study by Lau33 looking at patients with mean age of 71 years advocated 
ES + LC for choledocholithiasis. The authors stated that these patients should 
undergo ES + LC because of greater long-term morbidity and mortality in the ES-
alone group. However, closer look at this study reveals that the authors do not 
specifically mention immediate surgical mortality in patients undergoing 
cholecystectomy. Furthermore, the authors state that long-term mortality was 
higher in the ES-alone group. The long-term mortality rate estimates for ES-alone 
group vs. ES + LC group reveals that this is an estimation of ‘all causes of death’ 
rather than death caused by recurrent biliary complications. When one looks at 
long-term mortality from biliary complications alone among the two groups, the 
mortality rates are essentially the same.  
 
Hammarstrom et al.34 retrospectively evaluated 184 patients (mean age = 81 
years) to see whether ES with common bile duct calculi and the gall-bladder in 
situ should be followed by routine cholecystectomy. These patients were followed 
for median duration of 69 months. Cholecystectomy was required in only 35 
because of acute cholecystitis or biliary colic. The rest of patients who underwent 
ES alone were relatively asymptomatic. The findings in this study confirmed that 
endoscopic treatment alone in this group of patients was feasible treatment 
principle. Several other studies1, 35–37 have further confirmed that octogenarians 
with common bile duct calculi do well with ES alone on long-term follow-up.  
 
Targarona et al.38 carried out prospective trial of comparing ES + LC with that of 
ES for treatment of bile duct stones in patients with mean age of 80 years. 
Patients undergoing ES + LC had higher immediate morbidity when compared 
with the ES-alone group (23% vs. 16%). During mean follow-up of 17 months, 
the probability whether patients being free of biliary symptoms was higher in the 
ES + LC group than in the ES-alone group (85% and 61%, respectively). These 
findings contradict the findings of our decision analysis and the previously 
mentioned studies. It is important to understand that our decision analysis is 
predictive model that utilizes data from multiple clinical trials rather than just one 
trial. The conclusions of our model are hence based upon data compiled from 
various studies and hence may not always agree with an individual study 
mentioned above. Furthermore, our conclusions recommending the ES-alone 
strategy in patients more than 80 years of age have been validated by sensitivity 
analysis that accounts for the marked variability in outcomes seen in the 
literature.  
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The data analysis in our study indicates that for younger, relatively healthy 
patients, ES LC is the dominant strategy with an overall success rate of 90%. 
This result was further validated by sensitivity analysis. The mortality for the ES + 
LC group was also half that of the ES-alone group. ES alone is safe and effective 
procedure for most elderly patients with symptomatic cholelithiasis, including the 
extreme elderly, 80 years of age or older. When compared with other groups, 
elderly patients have much higher rate of conversion to an open 
cholecystectomy, more complications and mortality. Factors that account for 
these adverse outcomes include more comorbidities, especially coronary artery 
disease.  
 
In conclusion, on the basis of these observations, we recommend that in younger 
patients (age <70 years) with choledocholithiasis, ES followed by elective LC 
should be encouraged before the development of biliary complications. Such an 
approach may serve to lower complications and mortality. More elderly patients 
(age >70 years) with multiple comorbidities are at greatly increased risk for 
surgical morbidity and mortality and should be considered for ES alone.  
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TABLES & FIGURES 
 
 
TABLE 1 
Decision analysis baseline values for endoscopic sphincterotomy (ES) + 
laparoscopic cholecystectomy (LC) group. 
 
        ________________________________________________________________ 
Age (years)          Immediate            Immediate         Long-term                   Long-term 
                            complications       post-surgical      complications (%)       mortality (%) 
                            (%)                       mortality (%) 
_____________________________________________________________________________ 
Complications/mortality in ES + LC group 
   
  <70 27, 30, 39, 40 4 (2-7)  0.2  5.8 (0.5-8)   0.7 
  70-79 31, 39-46  11 (10-14) 2.2  5.8 (0.5-8)   0.7 
  >80 21, 31, 39, 40, 43-49 17 (16-19) 4.25  5.8 (0.5-8)   0.7 
______________________________________________________________________________________________________________________
 
 
  
 
 
TABLE 2 
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Decision analysis baseline values for endoscopic sphincterotomy (ES)-alone group. 
 
         ________________________________________________________________________ 
Age (years)                                  Long-term            Long-term 
                                            complications (%)        mortality (%) 
                                                     
_____________________________________________________________________________ 
Complications/mortality in ES-alone group 
   
  <70 27, 30, 34, 41, 47, 50-54   15 (5-24)  0.7 
  70-79 7, 31-35, 38, 41, 42, 47, 50-55  15 (11-20)  0.7 
  >80 7, 31, 32, 34, 45, 38, 41, 47, 50-54  15 (6-25)  0.7 
______________________________________________________________________________________________________________________
 
 
  
 
TABLE 3 
Decision model analysis results 
_____________________________________________________________________________ 
Age  ES  ES mortality ES + LC ES + LC 
(years)  success (%)  success mortality (%) 
_____________________________________________________________________________ 
<70  85  0.1  90  0.05 
70-79  85  0.1  83  0.34 
80+  86  0.1  78  0.76 
_____________________________________________________________________________ 
 
 
 
 
 
  
FIGURE 1  
Decision model tree used in our analysis. 
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FIGURE 2 
Results of sensitivity analysis showing a threshold surgical complication rate of 
9.8%, above which ES was the dominant strategy. 
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FIGURE 3 
Results of sensitivity analysis showing a threshold surgical complication rate of 
10%, above which ES was the dominant strategy. 
 
 
